The Toronto-Dominion Bank (TD)

pos +0.00
Today's Range: 0.00 - 0.00 | TD Avg Daily Volume: 1,303,900
Last Update: 02/23/17 - 4:02 PM EST
Volume: 0
YTD Performance: 8.78%
Open: $0.00
Previous Close: $53.54
52 Week Range: $37.67 - $54.44
Oustanding Shares: 1,857,587,302
Market Cap: 99,696,710,498
6-Month Chart
TheStreet Ratings Grade for TD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.20 2.20 2.20 2.20
Latest Dividend: 0.42
Latest Dividend Yield: 3.15%
Dividend Ex-Date: 01/06/17
Price Earnings Ratio: 15.42
Price Earnings Comparisons:
TD Sector Avg. S&P 500
15.42 15.40 30.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
13.49% 40.41% 20.23%
Revenue 7.10 -0.10 -0.02
Net Income 9.30 0.10 0.02
EPS 8.80 0.10 0.02
Earnings for TD:
Revenue 30.53B
Average Earnings Estimates
Qtr (01/17) Qtr (04/17) FY (10/17) FY (10/18)
Average Estimate $0.96 $0.93 $3.88 $4.17
Number of Analysts 2 2 4 3
High Estimate $0.98 $0.94 $3.97 $4.26
Low Estimate $0.93 $0.92 $3.84 $4.13
Prior Year $0.88 $0.90 $3.67 $3.88
Growth Rate (Year over Year) 8.52% 3.33% 5.86% 7.42%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
These other deals make a lot more sense than T-TWX.
It's not going to make you rich, but it should provide long-term appreciation and a healthy dividend.
Our neighbor to the north faces a "perfect storm" of problems.
They keep giving out low-cost commercial and industrial loans.

A Grim Future for Small Banks Real Money Pro($)

Many stand to get crushed under the weight of Dodd-Frank.
What follows boom is usually a bust.
Canadian banks are among my favorite income sources.

Tremendous Prospects for BBVA Real Money Pro($)

There's a litany of reasons to be bullish on this banking behemoth.

Columnist Conversations

The SPDR S&P Biotech ETF (XBI) was trading in a four month symmetrical triangle before it broke out o...
Join me later today as I bring back Toni Hanser to a webinar.  Toni has been away for awhile recovering f...
Here is a well defined zone to look for buy triggers against...defining the risk below it! View Char...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.